Is Provenge (sipuleucel-T) still available in the US?
Provenge is a prescription cancer immunotherapy (sipuleucel‑T). Public information indicates it was an FDA-approved treatment, but availability has been inconsistent over time due to commercial and production factors. At this point, it may be difficult to find depending on your location and your treatment center’s ability to obtain it.
How can I check if Provenge is available near me?
The fastest way to confirm current availability is to contact:
- Your oncologist or cancer center pharmacy (they can check whether they can order the product and schedule infusion)
- The treatment site’s specialty pharmacy network
- Your health insurer, which can tell you whether Provenge is covered and whether an in-network supplier is available
What if Provenge isn’t available—what are the usual alternatives?
If Provenge can’t be obtained, clinicians typically consider other prostate cancer options based on disease stage and prior treatments (for example, other immunotherapies, hormone therapy strategies, chemotherapy, radiation, or clinical trials). Your oncologist can map the alternatives to your specific situation.
Is Provenge still FDA-approved even if supply is limited?
Even when a product becomes hard to source, it can still remain an approved therapy. Availability depends on manufacturing/supply and whether a hospital/pharmacy can obtain it for patients.
What details should I share with my doctor to speed up the check?
Ask your doctor’s office to verify eligibility and logistics using:
- Your diagnosis and stage (including whether it’s metastatic castration-resistant prostate cancer)
- Prior treatments you’ve had
- Where you are located (so the center can check supply and shipping)
- Whether you’re receiving treatment within a clinical trial or standard-of-care pathway
If you tell me your country (and whether it’s for metastatic castration-resistant prostate cancer), I can tailor the most relevant next steps for checking availability where you are.